I have hpv. Protection from catching it again if my body gets rid of it?

I only just found out I enjoy a glorious risk type of hpv. The doctor told me to enjoy protected sex near my partner so that I won't shut in it again if my body get rid of the unexpected cell. The problem is I read that condoms won't totally protect me. What am I supposed to do?
Answers:

Lately, I've not be competent to receive to sleep til MN, and up at 6 am, broad awake! Any concept? Just not tired!?

Condoms do not provide 100% protection contained by acquire HPV.

There will other be a possibility that may share your infection next to a unusual sex partner.

You and your partner will not ping pong your virus fund and forth but condoms hold be shown to minister to the virus regress and to provide more protection to your cervix.

Your partner should own a accurate apparent exam to see if he have small flat wart. There is no DNA/HPV testing for the manly. Many men whose partner enjoy CIN will show small flat wart and it may lend a hand you if he have these wart removed. Unfortunately various men will enjoy the virus near no distinct signs. He does share your big risk HPV types.

If you and your current partner are within a committed relationship use condoms until you hold two clear Pap smears.

If you should acquire a current sex partner he should be told of your former HPV infection.

Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial.
Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, Westenend PJ, Meijer CJ.
Department of Gynaecology and Obstetrics, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Women next to unremitting HPV infections hold increased risk of progressive CIN lesion. Transmission of HPV between sexual partner might keep going viral infection and, consequently, may influence the clinical course of CIN. We investigated the effect of condom use on regression of CIN lesion and on clearance of HPV. Women next to CIN and their masculine sexual partner be randomized for condom use (condom group n = 72 and noncondom group n = 76). They be conservatively manage and followed every 3-6 months by colposcopy, cytology and HPV trialling by GP5+/6+ PCR. Baseline cervical biopsy specimens be taken. Median follow-up time for women be 15.2 months (range 3.0-85.4). Outcomes of interest be clinical regression of CIN at colposcopy and clearance of HPV. Outcomes be assessed surrounded by 64 women of the condom group and 61 women of the noncondom group. Women contained by the condom group showed a 2-year cumulative regression rate of 53% vs. 35% contained by the noncondom group (p = 0.03). The 2-year cumulative rates of HPV clearance be 23% vs. 4%, respectively (p = 0.02). Although lower regression rates be found if women be HPV-positive and have > or =CIN2 lesion at baseline, effects of condom use be found both within women next to CIN1 and surrounded by women next to > or =CIN2 lesion. Condom use promotes regression of CIN lesion and clearance of HPV..
PMID: 14566832